Lucid Diagnostics (LUCD) Treasury Shares (2021 - 2026)

Lucid Diagnostics (LUCD) has 6 years of Treasury Shares data on file, last reported at $12.3 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 86.74% year-over-year to $12.3 million; the trailing twelve-month figure through Mar 2026 stood at $12.3 million (up 86.74% YoY), and the FY2025 full-year result was $6.6 million, up 68.94% from the prior year.
• Treasury Shares for Q1 2026 stood at $12.3 million, up from $6.6 million in the prior quarter.
• Across five years, Treasury Shares topped out at $12.3 million in Q1 2026 and bottomed at $1.8 million in Q3 2023.
• The 5-year median for Treasury Shares is $2.3 million (2023), against an average of $4.1 million.
• The widest annual swing landed in 2023, when Treasury Shares dropped 17.19%; it then soared 186.59% in 2025.
• A 5-year view of Treasury Shares shows it stood at $2.1 million in 2022, then grew by 11.76% to $2.3 million in 2023, then soared by 66.74% to $3.9 million in 2024, then jumped by 68.94% to $6.6 million in 2025, then soared by 86.74% to $12.3 million in 2026.
• The last three Treasury Shares figures came in at $12.3 million (Q1 2026), $6.6 million (Q4 2025), and $6.6 million (Q3 2025), per Business Quant data.

Peer Comparison